Adaptimmune Therapeutics (ADAP) Narrows Q1 Loss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Form 6-K Adaptimmune Therapeutics For: Nov 13
November 13, 2015 7:35 AM EST
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION



